| ||||||||
|
||||||||
|
||||||||
|
||||||||
| Or | ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Search results for: "W"
Results 1 - 10 of 863 shown below 
|
||||||||
|
||||||||
|
||||||||
|
||||||||
| Aherne, W A O'Donnell, A Padhani, C Hayes, A J Kakkar, M Leach, J M Trigo, M Scurr, F Raynaud, S Phillips, W Aherne, A Hardcastle, P Workman, A Hannah and I Judson A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points doi:10.1038/sj.bjc.6602797 Abstract | Full article | PDF T Benepal, A Jackman, L Pyle, S Bate, A Hardcastle, W Aherne, F Mitchell, L Simmons, R Ruddle, F Raynaud and M Gore A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies advance online publication, 2005-10-11 00:00:00.000; doi:10.1038/sj.bjc.6602811 Abstract | Full article | PDF |
||||||||
| Alazawi, W W Alazawi, M Pett, S Strauss, R Moseley, J Gray, M Stanley and N Coleman Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome advance online publication, 2004-11-16 00:00:00.000; doi:10.1038/sj.bjc.6602237 Abstract | Full article | PDF |
||||||||
| Anderson, W F M García-Closas, L A Brinton, J Lissowska, N Chatterjee, B Peplonska, W F Anderson, N Szeszenia-D  browska, A Bardin-Mikolajczak, W Zatonski, A Blair, Z Kalaylioglu, G Rymkiewicz, D Mazepa-Sikora, R Kordek, S Lukaszek and M E Sherman
Established breast cancer risk factors by clinically important tumour characteristics advance online publication, 2006-06-06 00:00:00.000; doi:10.1038/sj.bjc.6603207 Abstract | Full article | PDF M García-Closas, L A Brinton, W F Anderson and M E Sherman Reply: Study design and statistics in epidemiology of breast cancer advance online publication, 2006-10-03 00:00:00.000; doi:10.1038/sj.bjc.6603371 Abstract | Full article | PDF |
||||||||
| Angerson, W J L M Forrest, D C McMillan, C S McArdle, W J Angerson, K Dagg and H R Scott A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer advance online publication, 2005-05-03 00:00:00.000; doi:10.1038/sj.bjc.6602591 Abstract | Full article | PDF J E M Crozier, R F McKee, C S McArdle, W J Angerson, J H Anderson, P G Horgan and D C McMillan The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer advance online publication, 2006-05-23 00:00:00.000; doi:10.1038/sj.bjc.6603185 Abstract | Full article | PDF A M Al Murri, C Wilson, A Lannigan, J C Doughty, W J Angerson, C S McArdle and D C McMillan Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer doi:10.1038/sj.bjc.6603682 Abstract | Full article | PDF M McKernan, D C McMillan, J R Anderson, W J Angerson and R C Stuart The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer advance online publication, 2008-02-12 00:00:00.000; doi:10.1038/sj.bjc.6604248 Abstract | Full article | PDF |
||||||||
| Ansell, W J Shamash, G Dancey, C Barlow, P Wilson, W Ansell and R T D Oliver Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding advance online publication, 2004-11-30 00:00:00.000; doi:10.1038/sj.bjc.6602263 Abstract | Full article | PDF J Shamash, T Powles, W Ansell, J Stebbing, K Mutsvangwa, P Wilson, S Asterling, S Liu, P Wyatt, S P Joel and R T D Oliver GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours advance online publication, 2007-07-03 00:00:00.000; doi:10.1038/sj.bjc.6603865 Abstract | Full article | PDF J Shamash, T Powles, W Ansell, D Berney, J Stebbing, K Mutsvangwa, P Wilson, S Asterling, S Liu, P Wyatt, S P Joel and R T D Oliver GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours doi:10.1038/sj.bjc.6604041 Abstract | Full article | PDF J Shamash, A Davies, W Ansell, S Mcfaul, P Wilson, T Oliver and T Powles A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer advance online publication, 2008-01-08 00:00:00.000; doi:10.1038/sj.bjc.6604051 Abstract | Full article | PDF |
||||||||
| Ansorge, W K Almstrup, C E Hoei-Hansen, J E Nielsen, U Wirkner, W Ansorge, N E Skakkebæk, E Rajpert-De Meyts and H Leffers Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours advance online publication, 2005-04-26 00:00:00.000; doi:10.1038/sj.bjc.6602560 Abstract | Full article | PDF |
||||||||
| Atkin, W S A G Renehan, W S Atkin, S T O'Dwyer and S M Shalet The effect of cigarette smoking use and cessation on serum insulin-like growth factors advance online publication, 2004-08-31 00:00:00.000; doi:10.1038/sj.bjc.6602150 Abstract | Full article | PDF |
||||||||
| Böcker, W A Sak, G Stueben, M Groneberg, W Böcker and M Stuschke Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines advance online publication, 2005-03-22 00:00:00.000; doi:10.1038/sj.bjc.6602457 Abstract | Full article | PDF P Wülfing, C Kersting, H Buerger, B Mattsson, R Mesters, C Gustmann, B Hinrichs, J Tio, W Böcker and L Kiesel Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ advance online publication, 2005-04-19 00:00:00.000; doi:10.1038/sj.bjc.6602567 Abstract | Full article | PDF |
||||||||
| Barranco, W T W T Barranco and C D Eckhert Cellular changes in boric acid-treated DU-145 prostate cancer cells advance online publication, 2006-02-21 00:00:00.000; doi:10.1038/sj.bjc.6603009 Abstract | Full article | PDF |
||||||||
| Basher, W J Zidan, I Dashkovsky, C Stayerman, W Basher, C Cozacov and A Hadary Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease advance online publication, 2005-08-16 00:00:00.000; doi:10.1038/sj.bjc.6602738 Abstract | Full article | PDF |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2008 Cancer Research UK | ||
| |||
| Privacy Policy | |||